Effect of taurine on IRAK4 and NF-kappa B in Kupffer cells from rat liver grafts after ischemia-reperfusion injury

Am J Surg. 2012 Sep;204(3):389-95. doi: 10.1016/j.amjsurg.2011.10.020. Epub 2012 Jul 6.

Abstract

Background: The aim of this study was to explore the protective mechanisms of taurine pretreatment against hepatic ischemia/reperfusion injury after liver transplantation.

Methods: A Sprague-Dawley-to-Sprague-Dawley rat liver transplantation model was used in this study. At 0, 60, and 180 minutes after reperfusion, expression of interleukin-1 receptor-associated kinase-4 (IRAK-4) messenger ribonucleic acid and protein in Kupffer cells was determined by real-time polymerase chain reaction and Western blotting. The activity of nuclear factor κB in Kupffer cells was determined by electrophoretic mobility shift assay. The serum tumor necrosis factor-α level was detected by enzyme-linked immunosorbent assay. Serum transaminases, liver histology, and animal survival were also investigated.

Results: At 60 and 180 minutes after reperfusion, levels of IRAK-4 messenger ribonucleic acid and protein, activities of nuclear factor κB, and levels of serum transaminases and tumor necrosis factor-α were all obviously elevated. However, changes in these parameters in rats treated with taurine were remarkably attenuated at the indicated time points.

Conclusions: These data suggest that taurine could protect against hepatic ischemia/reperfusion injury after liver transplantation, and the protective effects may be through downregulation of IRAK-4 and downstream nuclear factor κB and tumor necrosis factor-α expression in Kupffer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase / metabolism
  • Animals
  • Aspartate Aminotransferases / metabolism
  • Blotting, Western
  • Electrophoretic Mobility Shift Assay
  • Enzyme-Linked Immunosorbent Assay
  • Gene Expression Regulation, Enzymologic
  • Interleukin-1 Receptor-Associated Kinases / metabolism*
  • Kupffer Cells / drug effects
  • Kupffer Cells / enzymology*
  • Kupffer Cells / metabolism
  • Liver / enzymology*
  • Liver / metabolism
  • Liver / pathology
  • Liver Function Tests
  • Liver Transplantation* / adverse effects
  • Male
  • NF-kappa B / metabolism*
  • Primary Graft Dysfunction / etiology
  • Primary Graft Dysfunction / metabolism*
  • Primary Graft Dysfunction / pathology
  • Primary Graft Dysfunction / prevention & control*
  • Protective Agents / administration & dosage
  • Protective Agents / pharmacology*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Real-Time Polymerase Chain Reaction
  • Taurine / administration & dosage
  • Taurine / pharmacology*
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • NF-kappa B
  • Protective Agents
  • Tumor Necrosis Factor-alpha
  • Taurine
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Interleukin-1 Receptor-Associated Kinases